Overview

Clozapine-induced Hypersalivation - Feasibility Trial

Status:
Completed
Trial end date:
2018-02-23
Target enrollment:
Participant gender:
Summary
A randomised placebo-controlled feasibility study of glycopyrrolate and hyoscine in the treatment of clozapine-induced hypersalivation to assess recruitment and retention rates in a multi-centre trial.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Mersey Care NHS Trust
Collaborators:
Lancashire Care NHS Foundation Trust
Manchester Mental Health & Social Care Trust
University of Central Lancashire
University of Manchester
Treatments:
Bromides
Butylscopolammonium Bromide
Clozapine
Glycopyrrolate
Scopolamine
Scopolamine Hydrobromide